Immunoblotting results revealed higher expression of PCK1 and lower expression of TXNRD1 in tumor tissues derived from the PCK1-overexpressing hepatoma cells than in GFP control group (Figure 4E). The gene discussed is TXNRD1; the disease is hepatocellular carcinoma.